US equities
|
MU
$1,022.26
▼-1.31%
SPCX
$163.38
▲+1.75%
TSLA
$382.14
▲+1.90%
NVDA
$230.15
▼-0.15%
AAPL
$335.06
▼-1.57%
AMD
$613.09
▼-1.22%
SNDK
$1,597.77
▼-0.73%
LITE
$1,123.81
▲+7.17%
MU
$1,022.26
▼-1.31%
SPCX
$163.38
▲+1.75%
TSLA
$382.14
▲+1.90%
NVDA
$230.15
▼-0.15%
AAPL
$335.06
▼-1.57%
AMD
$613.09
▼-1.22%
SNDK
$1,597.77
▼-0.73%
LITE
$1,123.81
▲+7.17%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
West Pharmaceutical Services, Inc. Common Stock
(NY:
WST
)
367.93
+4.66 (+1.28%)
Delayed Quote
Updated: 11:27 AM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about West Pharmaceutical Services, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings
↗
July 24, 2025
The company also raised its outlook for the year following a first-quarter setback in February.
Via
Investor's Business Daily
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
↗
July 24, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Via
Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
July 24, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 24, 2025
Via
Benzinga
Earnings Scheduled For July 24, 2025
↗
July 24, 2025
Via
Benzinga
West Pharmaceutical Services (NYSE:WST) Surges 14.8% After Q2 2025 Earnings Beat Estimates
↗
July 24, 2025
West Pharmaceutical Services (WST) beats Q2 2025 earnings and revenue estimates, sparking a 14.8% pre-market rally. Strong demand and operational efficiency drive investor optimism.
Via
Chartmill
Topics
Earnings
West Pharmaceutical Services (NYSE:WST) Delivers Impressive Q2, Stock Jumps 11.1%
July 24, 2025
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 9.2% year on year to $766.5 million. The company’s...
Via
StockStory
Topics
Economy
A Glimpse of West Pharmaceutical Servs's Earnings Potential
↗
July 23, 2025
Via
Benzinga
West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For
July 22, 2025
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results this Thursday morning. Here’s what you need to know.
Via
StockStory
Topics
Artificial Intelligence
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know
July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...
Via
StockStory
Topics
Lawsuit
World Trade
What's going on in today's session: S&P500 movers
↗
July 18, 2025
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via
Chartmill
Top S&P500 movers in Friday's session
↗
July 18, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking West Pharmaceutical Services (NYSE:WST)
July 15, 2025
Let’s dig into the relative performance of West Pharmaceutical Services (NYSE:WST) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season.
Via
StockStory
Topics
Economy
WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 08, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals
July 07, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST
July 07, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST
July 07, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
July 06, 2025
From
Pomerantz LLP
Via
GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
July 06, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
3 Profitable Stocks Facing Headwinds
July 04, 2025
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...
Via
StockStory
Topics
Economy
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
July 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
July 03, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST
July 02, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST
July 02, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Deadline Soon: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
July 02, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
July 02, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
July 01, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
July 01, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
July 01, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm
June 30, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
